Anglosphere’s Awakening to COVID-19: Treat Mild-to-Moderate, Early Onset COVID with Cheap Antivirals

Anglosphere’s Awakening to COVID-19 Treat Mild-to-Moderate, Early Onset COVID with Cheap Antivirals

All those outspoken doctors weren’t wrong after all. You know, the ones that have been crying out for caring for mild-to-moderate COVID-19 patients at early onset of the infection. From Dr. Peter McCullough to Dr. Pierre Kory with the Front Line COVID-19 Critical Care Alliance (FLCCC) and many more, physicians have pleaded that the current approach to COVID-19 has been unethical and immoral. Why? Because 90% of COVID-19 patients fall into the category of either asymptomatic or mild-to-moderate symptoms, and the standard of care has been to send such patients home with no care and simple instructions to come back to the health center if the symptoms begin to worsen. That’s because healthcare and political leadership decided to emphasize first, massive spend on both vaccines and novel experimental therapeutics as evidenced in America by the National Institute of Health (NIH) and its partnership with the pharmaceutical industry via the ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines) program, which emphasized vaccines and novel therapeutic research from the start, frankly skipping 90% of the cases. Of course, TrialSite’s been chronicling this dynamic along with th...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee